- Home
- BACK vs XYLO Comparison
BACK vs XYLO Comparison
Compare BACK & XYLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACK
- XYLO
- Stock Information
- Founded
- BACK 2000
- XYLO 1999
- Country
- BACK United States
- XYLO Israel
- Employees
- BACK N/A
- XYLO N/A
- Industry
- BACK Medical Specialities
- XYLO
- Sector
- BACK Health Care
- XYLO
- Exchange
- BACK Nasdaq
- XYLO NYSE
- Market Cap
- BACK 2.2M
- XYLO 2.3M
- IPO Year
- BACK 2019
- XYLO N/A
- Fundamental
- Price
- BACK $1.10
- XYLO $3.15
- Analyst Decision
- BACK
- XYLO
- Analyst Count
- BACK 0
- XYLO 0
- Target Price
- BACK N/A
- XYLO N/A
- AVG Volume (30 Days)
- BACK 23.2K
- XYLO 17.6K
- Earning Date
- BACK 12-31-2024
- XYLO 12-27-2024
- Dividend Yield
- BACK N/A
- XYLO N/A
- EPS Growth
- BACK N/A
- XYLO N/A
- EPS
- BACK N/A
- XYLO N/A
- Revenue
- BACK N/A
- XYLO $57,642,000.00
- Revenue This Year
- BACK N/A
- XYLO N/A
- Revenue Next Year
- BACK N/A
- XYLO N/A
- P/E Ratio
- BACK N/A
- XYLO N/A
- Revenue Growth
- BACK N/A
- XYLO N/A
- 52 Week Low
- BACK $0.98
- XYLO $2.70
- 52 Week High
- BACK $7.75
- XYLO $10.43
- Technical
- Relative Strength Index (RSI)
- BACK 45.18
- XYLO 39.41
- Support Level
- BACK $1.06
- XYLO $3.11
- Resistance Level
- BACK $1.21
- XYLO $3.90
- Average True Range (ATR)
- BACK 0.10
- XYLO 0.31
- MACD
- BACK 0.01
- XYLO -0.05
- Stochastic Oscillator
- BACK 29.17
- XYLO 2.94
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
About XYLO XYLO TECHNOLOGIES LTD
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in five segments namely, E-Commerce, Online Advertising & Internet Traffic Routing, Online Event Management, Corporate, and others. The company's geographical segments include the United States, Europe, Great Britain, Israel, Canada, Asia, and others.